ArticleThe Libyan journal of medicine2010
Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings.
Article in The Libyan journal of medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 81 citations in OpenAlex.
- Phenotypic and Molecular Assessment ofPathogens (Basel, Switzerland) · 2026Article
- Usefulness of Chromogenic Media in the Identification ofMethods and protocols · 2025Article
- Fluconazole resistant pathogenic yeasts isolated from plastic debris on recreational public beaches in West and East Africa.Biologia · 2025Article
- The Effect ofClinical, cosmetic and investigational dentistry · 2025Article
- Identification of fungal pathogens among COVID-19 and non COVID-19 cases in Bhaktapur hospital, Nepal.BMC research notes · 2024Article
- Article
- Disseminated Lodderomyces elongisporus and Pantoea dispersa: A Rare Dual Infection in an Immunocompromised Patient.Cureus · 2024Article
- Antifungal and antibiofilm effects of probioticFrontiers in cellular and infection microbiology · 2024Article
- Five-year cross-sectional study to determine the burden ofBMJ open · 2023Article
- Denture Stomatitis and Candida albicans in the Indian Population: A Systematic Review and Meta-Analysis.Cureus · 2023Review
- Evaluation of the Various Oral Candida Species among Patients on Hemodialysis: A Clinical Study.Journal of pharmacy & bioallied sciences · 2023Article
- Molecular epidemiology of clinically relevant single and mixed species in a Malaysian tertiary care hospital.Current medical mycology · 2023Article
- In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.Mycopathologia · 2023Article
- Identification of Pathogenic and Opportunistic Yeasts in Pigeon Excreta by MALDI-TOF Mass Spectrometry and Their Prevalence in Chon Buri Province, Thailand.International journal of environmental research and public health · 2023Article
- Article
- Utility of CHROMagar™ Candida Plus for presumptive identification of Candida auris from surveillance samples.Mycopathologia · 2022Article
- Epidemiology and molecular identification of mixed yeast isolates in Malaysia: A way forward.Current medical mycology · 2022Article
- Prevalence ofJournal of pharmacy & bioallied sciences · 2022Article
- Susceptibility of Fluconazole-ResistantMicroorganisms · 2021Article
- Investigation of Candidal Species among People Who Suffer from Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.Journal of pharmacy & bioallied sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIdentification of yeast isolated from clinical specimens to the species level has become increasingly important. Ever-increasing numbers of immuno-suppressed patients, a widening range of recognized pathogens, and the discovery of resistance to antifungal drugs are contributing factors to this necessity. MATERIAL AND
methodsA total of 487 yeast strains were studied for the primary isolation and presumptive identification, directly from clinical specimen. Efficacy of CHROMagar Candida has been evaluated with conventional methods including morphology on Corn meal-tween 80 agar and biochemical methods by using API 20 C AUX.
resultsThe result of this study shows that CHROMagar Candida can easily identify three species of Candida on the basis of colonial color and morphology, and accurately differentiate between them i.e. Candida albicans, Candida tropicalis, and Candida krusei. The specificity and sensitivity of CHROMagar Candida for C. albicans calculated as 99%, for C. tropicalis calculated as 98%, and C. krusei it is 100%.
conclusionThe data presented supports the use of CHROMagar Candida for the rapid identification of Candida species directly from clinical specimens in resource-limited settings, which could be very helpful in developing appropriate therapeutic strategy and management of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.